Kailash Mosalpuria
University of Nebraska Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kailash Mosalpuria.
Journal of Oncology Practice | 2016
Daniel Almquist; Kailash Mosalpuria; Apar Kishor Ganti
Limited-stage small-cell lung cancer (SCLC) occurs in only one third of patients with SCLC, but it is potentially curable. Combined-modality therapy (chemotherapy and radiotherapy) has long been the mainstay of therapy for this condition, but more recent data suggest a role for surgery in early-stage disease. Prophylactic cranial irradiation seems to improve outcomes in patients who have responded to initial therapy. This review addresses the practical aspects of staging and treatment of patients with limited-stage SCLC.
Therapeutic Advances in Medical Oncology | 2015
Vijaya Raj Bhatt; Rajesh Shrestha; Jairam Krishnamurthy; Kailash Mosalpuria; Fausto R. Loberiza; Apar Kishor Ganti; Peter T. Silberstein
Background: The incidence of melanoma in older patients is on the rise. Prior studies have shown disparities in surgical management and poor survival of older patients with melanoma. Methods: This is a retrospective study of adult patients diagnosed with cutaneous invasive and in situ melanoma between 2000 and 2011 in the National Cancer Data Base. Characteristics and management of older patients (≥60 years) were compared with younger patients (20–59 years) using χ2 testing. Results: Of 476,623 total cases, 54% (n = 258,153) were diagnosed among older patients. The reported cases in the older patients increased by 1.74-fold between 2000 and 2011. The majority were white (96%), men (65%), with early-stage disease (76% stage 0-II), and superficial spreading melanoma histology (39%). Older patients, compared with younger patients, were more likely to be men (65% versus 49%, p < 0.0001), and have in situ melanoma (28% versus 21%, p < 0.0001); less likely to have nodal metastases (7% versus 9%, p < 0.0001), receive care in academic centers (30% versus 35%, p < 0.0001), undergo wide excision or major amputation for stage I–III disease (68% versus 72%, p < 0.0001) and systemic therapy for stage III (18% versus 45%, p < 0.0001) and IV disease (30% versus 50%, p < 0.0001). Conclusion: Older patients with melanoma are less likely to receive care in academic centers, undergo wide excision for stage I–III disease and receive systemic therapy for stage III–IV disease. Particularly, the utilization of systemic therapy is markedly low. This disparity is particularly important with the availability of less intense more effective therapies.
Journal of Community Hospital Internal Medicine Perspectives | 2014
Vijaya Raj Bhatt; Madan Raj Aryal; Sujana Panta; Kailash Mosalpuria; James O. Armitage
Background Although medical publications are frequently used as the source of information, the prevalence of errata remains unclear. The objective of this study was to examine peer-review and publication processes of medical journals as well as to determine the occurrence of reported errata in medical journals and timeliness in identifying and correcting errata. Methods Five medical journals, New England Journal of Medicine, Annals of Internal Medicine, British Medical Journal, Journal of American Medical Association, and Lancet, were evaluated. The characteristics of these journals were obtained from editors’ survey. All these journals report errata noted in their prior publications. We retrospectively analyzed all errata reported from January 1, 2012, to December 31, 2012. The mean number of reported errata per issue, the most common errata, and the mean time to report errata were calculated. Results The journals had high impact factors (14–51), received 3,200 to more than 15,000 submissions in 2012, and utilized two or more external reviewers and usually two or more editors for any accepted articles. All the journals edited the accepted articles, including references, figures, and tables for style. A mean of 1.3 articles with ≥1 errata was reported per issue (a total of 306 articles with errata in 226 issues). Errata in authors information, numeric errata, and errata in the figures and tables were the most common errata. The mean time to report the errata was 122 days. Conclusion The high-impact journals, with extensive pre-publication review, reported relatively few errata per issue. The delay in reporting errata needs further exploration.
Leukemia & Lymphoma | 2015
Kailash Mosalpuria; Fausto R. Loberiza
Journal of Clinical Oncology | 2017
Vijaya Raj Bhatt; Rajesh Shrestha; Jairam Krishnamurthy; Kailash Mosalpuria; Fausto R. Loberiza; Apar Kishor Ganti; Peter T. Silberstein
Journal of Clinical Oncology | 2017
Kailash Mosalpuria; Ryan C. Ramaekers; Mehmet Sitki Copur; Kenneth H. Cowan; Mary Mailliard; Elizabeth Lyden; Wajeeha Razaq; Elizabeth C. Reed
Journal of Clinical Oncology | 2017
Kailash Mosalpuria; Yan Xing; Chung-Yuan Hu; Vijaya Raj Bhatt; Apar Kishor Ganti
Journal of Clinical Oncology | 2017
Yan Xing; Kailash Mosalpuria; Chung-Yuan Hu; Vijaya Raj Bhatt; Apar Kishor Ganti
World Journal of Hepatology | 2016
Shadi Hamdeh; Abd Almonem M. Abdelrahman; Osama Elsallabi; Ranjan Pathak; Smith Giri; Kailash Mosalpuria; Vijaya Raj Bhatt
Archive | 2016
Daniel Almquist; Kailash Mosalpuria; Apar Kishor P Ganti